Javier Villela-Castrejón

Dr. Javier Villela-Castrejón

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Diamond and Related Materials
Verified
Journal Article
Closed access
Narsimha MamidiNarsimha Mamidi
Narsimha Mamidi
MGMarcelo Renato Martínez Gamero
Marcelo Renato Martínez Gamero
JVJavier Villela-Castrejón
Javier Villela-Castrejón
Alex Elías-ZúñigaAlex Elías-Zúñiga
Alex Elías-Zúñiga

1 November 2019 in Journal of Cereal Science
Verified
Journal Article
Closed access
BABeatriz A. Acosta-Estrada
Beatriz A. Acosta-Estrada
JVJavier Villela-Castrejón
Javier Villela-Castrejón
EPEsther Perez-Carrillo
Esther Perez-Carrillo
CGCarlos Eduardo Gómez-Sánchez
Carlos Eduardo Gómez-Sánchez
JGJanet A. Gutiérrez-Uribe
Janet A. Gutiérrez-Uribe

Verified
Journal Article
Open access
PDF file
JSJesús Santana-Gálvez
Jesús Santana-Gálvez
JVJavier Villela-Castrejón
Javier Villela-Castrejón
SSSergio Serna Saldivar
Sergio Serna Saldivar
LCLuis Cisneros-Zevallos
Luis Cisneros-Zevallos
Daniel Jacobo-VelázquezDaniel Jacobo-Velázquez
Daniel Jacobo-Velázquez
Nutraceutical combinations that act synergistically could be a powerful solution against colon cancer, which is the second deadliest malignancy worldwide. In this study, curcumin (C), sulforaphane (S), and dihydrocaffeic acid (D, a chlorogenic acid metabolite) were evaluated, individually and in different combinations, over the viability of HT-29 and Caco-2 colon cancer cells, and compared against healthy fetal human colon (FHC) cells. The cytotoxic concentrations to kill 50%, 75%, and 90% of the cells (CC50, CC75, and CC90) were obtained, using the MTS assay. Synergistic, additive, and antagonistic effects were determined by using the combination index (CI) method. The 1:1 combination of S and D exerted synergistic effects against HT-29 at 90% cytotoxicity level (doses 90:90 µM), whereas CD(1:4) was synergistic at all cytotoxicity levels (9:36–34:136 µM) and CD(9:2) at 90% (108:24 µM) against Caco-2 cells. SD(1:1) was significantly more cytotoxic for cancer cells than healthy cells, while CD(1:4) and CD(9:2) were similarly or more cytotoxic for healthy cells. Therefore, the SD(1:1) combination was chosen as the best. A model explaining SD(1:1) synergy is proposed. SD(1:1) can be used as a basis to develop advanced food products for the prevention/co-treatment of colon cancer.

1 December 2017 in MRS Communications
Verified
Journal Article
Closed access
PDF file
Narsimha MamidiNarsimha Mamidi
Narsimha Mamidi
HGHéctor Manuel Leija Gutiérrez
Héctor Manuel Leija Gutiérrez
JVJavier Villela-Castrejón
Javier Villela-Castrejón
LILucas Isenhart
Lucas Isenhart
EBEnrique V. Barrera
Enrique V. Barrera
Alex Elías-ZúñigaAlex Elías-Zúñiga
Alex Elías-Zúñiga

14 August 2017 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
Narsimha MamidiNarsimha Mamidi
Narsimha Mamidi
HLHéctor Manuel Leija
Héctor Manuel Leija
JDJose Manuel Diabb
Jose Manuel Diabb
IRIrasema Lopez Romo
Irasema Lopez Romo
DHDiana Hernandez
Diana Hernandez
Alex Elías-ZúñigaAlex Elías-Zúñiga
Alex Elías-Zúñiga

6 December 2019 in Polymers
Verified
Journal Article
Open access
PDF file
Rodrigo Ortiz-HernándezRodrigo Ortiz-Hernández
Rodrigo Ortiz-Hernández
NCNicolás Antonio Ulloa Castillo
Nicolás Antonio Ulloa Castillo
JZJosé Manuel Diabb Zavala
José Manuel Diabb Zavala
AVAlejandro Estrada-De La Vega
Alejandro Estrada-De La Vega
JIJorge Islas-Urbano
Jorge Islas-Urbano
Alex Elías-ZúñigaAlex Elías-Zúñiga
Alex Elías-Zúñiga
This research focuses on developing a novel ultra high molecular weight polyethylene (UHMWPE) material reinforced with titanium dioxide (TiO 2 ) nanoparticles for producing craniofacial prostheses via an incremental sheet forming process (SPIF). First, UHMWPE-TiO 2 nanocomposite sheets were produced using incipient wetting and the compression molding process by considering different concentrations of TiO 2 nanoparticles. Then, the influence that the compression molding fabrication process has on the crystallinity and structural properties of the produced sample sheets was investigated. Experimental characterizations via scanning electron microscopy (SEM), differential scanning calorimetry (DSC), X-ray diffraction (XRD), Fourier transform infrared (FT-IR), tensile mechanical testing, and live/dead cell viability assays provided data that show an enhancement of the physical, mechanical, and biological properties. Finally, modifications on the nanocomposite material properties due to the SPIF manufacturing processes of a craniofacial prosthesis are addressed.